Viral Hepatitis Updates from the HHS Office of Infectious Disease and HIV/AIDS Policy
Dear Colleague,
Speakers have been announced for the upcoming webinar, “Syringe Service Programs: State and Local Perspectives on the Role of Policy, Funding, and Partnerships ,” Monday, September 16, at 2:00-3:15 PM ET. Hosted by the HHS Office of Assistant Secretary for Health, this second in a three-part series about syringe service programs, or SSPs, will feature examples from state government highlighting experiences in gaining statewide support and community buy-in, crafting policy and bringing it to practice, and building strong partnerships with local communities to support SSP growth. You can register for the webinar here.
Speakers include:
Speakers have been announced for the upcoming webinar, “Syringe Service Programs: State and Local Perspectives on the Role of Policy, Funding, and Partnerships ,” Monday, September 16, at 2:00-3:15 PM ET. Hosted by the HHS Office of Assistant Secretary for Health, this second in a three-part series about syringe service programs, or SSPs, will feature examples from state government highlighting experiences in gaining statewide support and community buy-in, crafting policy and bringing it to practice, and building strong partnerships with local communities to support SSP growth. You can register for the webinar here.
Speakers include:
- ADM Brett Giroir, MD, Assistant Secretary for Health and Senior Advisor for Opioid Policy
- Connie Gayle White, MD, MS, FACOG, Deputy Commissioner for Clinical Services, Kentucky Department for Public Health
- Danny Staley, MS, Association of State and Territorial Health Officials, former director of the North Carolina Division of Public Health
- Andrew Gans, MPH, HIV, STD and Hepatitis Section Manager, New Mexico Department of Health
- Joshua Swatek, Hepatitis and Harm Reduction Program Manager, New Mexico Department of Health
During the first webinar in the series, speakers from across the Department of Health and Human Services discussed how they support SSPs, including: the Centers for Disease Control and Prevention (CDC), the Health Resources and Services Administration (HRSA), and the Substance Abuse and Mental Health Services Administration (SAMHSA). You can listen to a recording of that webinar.
Comprehensive SSPs are community-based prevention programs that are proven to be safe, effective, and cost-saving, do not increase illegal drug use or crime, and play an important role in reducing the transmission of infectious diseases. These programs provide a range of services, including linkage to substance use disorder treatment; access to and disposal of sterile syringes and injection equipment; and vaccination, testing, and linkage to care and treatment for infectious diseases, including hepatitis B and C.
SSPs protect the public and first responders by facilitating the safe disposal of used needles and syringes. Providing testing, counseling, and sterile injection supplies also helps prevent outbreaks of other diseases.
We hope you join us to learn about how policy, funding, and partnerships shape successful SSP development and implementation.
Corinna Dan, RN, MPH
Office of Infectious Disease and HIV/AIDS Policy
U.S. Department of Health and Human Service
Comprehensive SSPs are community-based prevention programs that are proven to be safe, effective, and cost-saving, do not increase illegal drug use or crime, and play an important role in reducing the transmission of infectious diseases. These programs provide a range of services, including linkage to substance use disorder treatment; access to and disposal of sterile syringes and injection equipment; and vaccination, testing, and linkage to care and treatment for infectious diseases, including hepatitis B and C.
SSPs protect the public and first responders by facilitating the safe disposal of used needles and syringes. Providing testing, counseling, and sterile injection supplies also helps prevent outbreaks of other diseases.
We hope you join us to learn about how policy, funding, and partnerships shape successful SSP development and implementation.
Corinna Dan, RN, MPH
Office of Infectious Disease and HIV/AIDS Policy
U.S. Department of Health and Human Service
No hay comentarios:
Publicar un comentario